Sort
326,823 grants matching “clinical trial”
Organized Lipid Matrix: Fatty Acids and Choline in CF
$2,101,037Walter A Shaw · Avanti Polar Lipids, Inc. · R44 · FY2006 · DK
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,101,022Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2023 · AI
Noninvasive Markers and Transplant Outcome in Humans
$2,100,841Cleveland Clinic Lerner Col/Med-Cwru · U01 · FY2004 · AI
Specialized Center for Cell Based Therapy
$2,100,783Henry M Kronenberg · Massachusetts General Hospital · U54 · FY2006 · HL
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,100,780Joel Moss · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Indiana Alzheimer Disease Center
$2,100,491Andrew J Saykin · Indiana University Indianapolis · P30 · FY2016 · AG
Neuroprotection Studies in PD: A Coordinating Center
$2,100,369Karl D. Kieburtz · University Of Rochester · U01 · FY2008 · NS
DEVELOPMENT OF DIAGNOSTICS FOR NEISSERIA GONORRHEAOE
$2,100,300Jeffrey Klausner · Social And Scientific Systems, Inc. · N01 · FY2015 · AI
Mechanisms of IL-6 mediated T cell pathogenesis in autoimmunity
$2,100,193Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AI
DCTD In Vivo Preclinical Testing
$2,100,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
CLINICAL RESEARCH COOPERATIVE
$2,100,000University Of Pennsylvania · U10 · FY2001 · DA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,100,000Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2017 · CA
Cancer Center Support (CORE) Grant
$2,100,000Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2017 · CA
Cancer Center Support (CORE) Grant
$2,100,000Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2016 · CA
DCTD Computer Support
$2,100,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Cancer Center Support (CORE) Grant
$2,100,000Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2018 · CA
Critical Path Public Private Partnerships
$2,100,000Klaus Romero · Critical Path Institute · U18 · FY2024 · FD
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK
$2,100,000Oregon Health And Science University · U10 · FY2001 · DA
Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial
$2,100,000Judith A Kelleher-Andersson · Neuronascent, Inc. · U01 · FY2023 · AG
Establishment of a Rare Disease Clinical Outcome Assessment Consortium
$2,099,999Stephen Joel Coons · Critical Path Institute · U01 · FY2019 · FD
Psychotherapy Development Research Center
$2,099,882Kathleen M Carroll · Yale University · P50 · FY2012 · DA
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$2,099,783Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2023 · AI
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$2,099,717D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2014 · TR
Molecular Mechanism of Action of Phorbol Ester
$2,099,708Peter Blumberg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Drug Combination Signatures for Prediction and Mitigation of Toxicity
$2,099,686Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2014 · HG